Search company, investor...

Total Raised

$130M

Investors Count

13

Deal Terms

2

Funding, Valuation & Revenue

7 Fundings

Blackthorn Therapeutics has raised $130M over 7 rounds.

Blackthorn Therapeutics's latest funding round was a Series B for $76M on June 13, 2019.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

6/13/2019

Series B

$76M

$99M

0

FY undefined

8

6/20/2017

Grant

$99M

0

FY undefined

10

1/5/2017

Series A - II

$99M

$99M

0

FY undefined

10

10/20/2016

Series A

$99M

$99M

0

FY undefined

10

9/9/2015

Incubator/Accelerator

$99M

0

FY undefined

10

Date

6/13/2019

6/20/2017

1/5/2017

10/20/2016

9/9/2015

Round

Series B

Grant

Series A - II

Series A

Incubator/Accelerator

Amount

$76M

$99M

$99M

Investors

Valuation

$99M

$99M

$99M

$99M

$99M

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

8

10

10

10

10

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo
CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Blackthorn Therapeutics Deal Terms

2 Deal Terms

Blackthorn Therapeutics's deal structure is available for 2 funding rounds, including their Series A - II from January 05, 2017.

Round

Series A - II

Series A

Funding Date

$99M

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

$99M

Shares Authorized

Issuance Price

$99M

$99M

Dividend Rate

$99M

$99M

Liquidation Preferences

$99M

$99M

Liquidation Price

Participation

Conversion Price

Anti Dilution

$99M

$99M

General Voting

$99M

$99M

Board Voting

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series A - II

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series A

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Blackthorn Therapeutics Investors

13 Investors

Blackthorn Therapeutics has 13 investors. ARCH Venture Partners invested in Blackthorn Therapeutics's Series B funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

1/29/2014

6/13/2019

3
Seed VC, Series A (2016), Series B (2019)

Venture Capital

Illinois

1/1/2013

6/13/2019

2
Spinoff / Spinout, Series B (2019)

Academic/University

California

1/5/2017

6/13/2019

2
Series A - II, Series B (2019)

Corporate Venture

California

00/00/0000

00/00/0000

Alexandria Venture Investments

Subscribe to see more

Corporate Venture

California

00/00/0000

00/00/0000

Biomatics Capital Partners

Subscribe to see more

Venture Capital

Washington

First funding

1/29/2014

1/1/2013

1/5/2017

00/00/0000

00/00/0000

Last Funding

6/13/2019

6/13/2019

6/13/2019

00/00/0000

00/00/0000

Investor

Alexandria Venture Investments

Biomatics Capital Partners

Rounds

3
Seed VC, Series A (2016), Series B (2019)
2
Spinoff / Spinout, Series B (2019)
2
Series A - II, Series B (2019)

Subscribe to see more

Subscribe to see more

Board Seats

Type

Venture Capital

Academic/University

Corporate Venture

Corporate Venture

Venture Capital

Location

Illinois

California

California

California

Washington

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.